GRIBBON Philip

Philip is Head of Discovery Research at the Fraunhofer ITMP and is involved in several national and European consortia working on targeted protein degradation, target validation, and compound repurposing especially in the rare disease setting. He also serves as Director General of the European Infrastructure for Chemical Biology, EU-OPENSCREEN, and as President of the Society of Laboratory Automation and Screening (SLAS). Previously, Philip was Chief Scientific Officer of the European ScreeningPort GmbH Hamburg, Germany, and has experience working in Pharma in drug discovery roles. https://orcid.org/0000-0001-7655-2459